KORDASTI, Shahram Yaser
 Distribuzione geografica
Continente #
NA - Nord America 1.482
EU - Europa 388
AS - Asia 215
AF - Africa 36
SA - Sud America 20
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.144
Nazione #
US - Stati Uniti d'America 1.481
SG - Singapore 114
IE - Irlanda 104
IT - Italia 103
SE - Svezia 77
CN - Cina 64
FR - Francia 38
CI - Costa d'Avorio 28
GB - Regno Unito 28
IN - India 25
BR - Brasile 17
AT - Austria 8
DE - Germania 7
NL - Olanda 6
VN - Vietnam 6
MA - Marocco 5
FI - Finlandia 4
ES - Italia 3
EU - Europa 3
DK - Danimarca 2
HK - Hong Kong 2
MT - Malta 2
RU - Federazione Russa 2
TN - Tunisia 2
TR - Turchia 2
AR - Argentina 1
BE - Belgio 1
CA - Canada 1
CO - Colombia 1
GE - Georgia 1
KR - Corea 1
LT - Lituania 1
LU - Lussemburgo 1
UA - Ucraina 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 2.144
Città #
Des Moines 380
Chandler 310
Dublin 103
Boardman 95
Ashburn 81
Fairfield 67
Singapore 58
Lawrence 30
Princeton 30
Abidjan 28
San Mateo 28
Wilmington 28
Pune 25
Woodbridge 21
Seattle 19
Turin 19
Falls Church 18
Houston 17
Cambridge 16
Marche 16
Ancona 15
Los Angeles 14
Ann Arbor 13
New York 12
Milan 11
San Diego 11
Washington 10
Shanghai 8
Vienna 8
Dallas 7
Norwalk 7
Dong Ket 6
Falconara Marittima 6
Amsterdam 4
Guangzhou 4
London 4
Andria 3
Aversa 3
Beijing 3
Chiswick 3
Jiaxing 3
Lincoln 3
Monza 3
Nuremberg 3
Phoenix 3
Rome 3
Agrate Conturbia 2
Buffalo 2
Copenhagen 2
Fano 2
Hangzhou 2
Helsinki 2
Istanbul 2
Msida 2
Palo Alto 2
Prescot 2
Rho 2
San Antonio 2
Shenzhen 2
Southwark 2
Spalding 2
Stamford 2
Watford 2
Wuxi 2
Berlin 1
Bragança Paulista 1
Brussels 1
Caraguatatuba 1
Caxias do Sul 1
Caçapava do Sul 1
Central 1
Córdoba 1
Dongyang 1
Frankfurt am Main 1
Fuzhou 1
Garanhuns 1
Genoa 1
Hengshui 1
Hounslow 1
Iesi 1
Islington 1
Jinhua 1
Juiz de Fora 1
Kilburn 1
Kilkenny 1
Las Vegas 1
Luxembourg 1
Medellín 1
Mogi Guaçu 1
Naaldwijk 1
Nanjing 1
New Bedfont 1
Nova Iguaçu 1
Osimo 1
Pato Bragado 1
Pescara 1
Pistoia 1
Posadas 1
Pretoria 1
Recife 1
Totale 1.631
Nome #
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells 91
Deep phenotyping of tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment 88
Treg sensitivity to FasL and relative IL-2 deprivation drive idiopathic aplastic anemia immune dysfunction 77
COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients 68
Integrating the “Immunome” in the stratification of myelodysplastic syndromes and future clinical trial design 68
Human retinoic acid–regulated CD161 + regulatory T cells support wound repair in intestinal mucosa 67
Thrombomodulin-expressing monocytes are associated with low-risk features in myelodysplastic syndromes and dampen excessive immune activation 65
Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes 63
Anti-TNF treatment negatively regulates human CD4+ T-cell activation and maturation in vitro, but does not confer an anergic or suppressive phenotype 63
Immunocluster provides a computational framework for the nonspecialist to profile high-dimensional cytometry data 62
Deep phenotyping detects a pathological CD4+ T-cell complosome signature in systemic sclerosis 61
Macrophages orchestrate the expansion of a proangiogenic perivascular niche during cancer progression 61
Pitfalls in the characterization of circulating and tissue-resident human γδ T cells 59
Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation 58
Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre 56
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes 56
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms 56
Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London 55
Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 54
Human bone marrow-derived myeloid dendritic cells show an immature transcriptional and functional profile compared to their peripheral blood counterparts and separate from slan+ non-classical monocytes 53
Targeting the immune system in MDS and MPN: Understanding the immunome and response to immunotherapy - Part 2 52
SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation 52
Cluster stability in the analysis of mass cytometry data 51
Repurposing tin mesoporphyrin as an immune checkpoint inhibitor shows therapeutic efficacy in preclinical models of cancer 51
Altered immune response to the annual influenza A vaccine in patients with myeloproliferative neoplasms 50
Transcriptional profiling reveals functional dichotomy between human slan+ non-classical monocytes and myeloid dendritic cells 50
Patients with triple-negative, JAK2V617F- A nd CALR-mutated essential thrombocythemia share a unique gene expression signature 49
Essential thrombocythaemia treated with recombinant interferon: ‘real world' United Kingdom referral centre experience 48
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients 47
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group 46
A Crohn's disease-associated IL2RA enhancer variant determines the balance of T cell immunity by regulating responsiveness to IL-2 signaling 45
Chronic Myelomonocytic Leukemia Diagnosis By Flow Cytometry: An Italian Center Experience 43
Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T-cell phenotype 34
Natural born survivors: The inglorious TP53 33
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes 28
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study 27
Hostile Takeover: Tregs Expand in IFNγ-Rich AML Microenvironment 22
Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralisation in patients with chronic myeloid disorders 19
Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib 19
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1-mutated myelodysplasia 18
Regulatory T cell niche in the bone marrow, a new player in Haematopoietic stem cell transplantation 17
Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms 17
Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis 15
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 13
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium 13
Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model development 13
A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 years of COVID-19 epidemic in Iran 9
Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation 9
Marginal Zone Lymphoma Manifesting as Macrophage Activation Syndrome: A Case Report 8
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: Position paper of an International Consortium and the European LeukemiaNet Working Group 7
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS) 7
Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4 + T cells in a subset of cultures 6
Standardization of flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet Working Group 6
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS) 6
Chronic relapsing remitting Sweet syndrome - a harbinger of myelodysplastic syndrome 6
Neoantigens in MDS Are Associated with Two Novel CD4+T Cell Subsets and Improved Overall Survival 5
Dendritic cells in myelodysplastic syndromes: From pathogenesis to immunotherapy 5
IL-17-producing CD4+ T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome 5
Baseline cytokine profiling identifies novel risk factors for invasive fungal disease among haematology patients undergoing intensive chemotherapy or haematopoietic stem cell transplantation 5
The impact of COVID-19 in the cancer population stratified by age: A real-world data study from Guy's Cancer Center 5
CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner 5
Functional characterization of CD4+ T cells in aplastic anemia 4
JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells 4
Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab 4
Successful treatment of aplastic anaemia associated with HIV infection with eltrombopag: Implications for a possible immunomodulatory role 4
The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome 4
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party 4
LYVE-1+ macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancer 4
Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: Implications for a phase i clinical study 3
Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome 3
Totale 2.281
Categoria #
all - tutte 17.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.703


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021116 0 0 0 0 0 0 0 0 0 0 77 39
2021/2022331 2 79 0 1 12 32 7 9 33 20 52 84
2022/2023997 73 95 33 73 43 420 0 40 151 2 52 15
2023/2024460 71 26 32 40 66 74 14 14 0 49 17 57
2024/2025377 75 117 46 18 47 73 1 0 0 0 0 0
Totale 2.281